IDH3A and neoplasm: The expression of CCL5 in CD146+ pericytes and tumor recurrence status of two representative isocitrate dehydrogenase (IDH)-wild-type GBM patients (Case 1: CCL5high/CD146high and Case 2: CCL5low/CD146low) were assessed.